HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alessandra Prete Selected Research

Immune Checkpoint Inhibitors

1/2016Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alessandra Prete Research Topics

Disease

2Colorectal Neoplasms (Colorectal Cancer)
01/2019 - 11/2013
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2016
1Circulating Neoplastic Cells
01/2016
1Neoplasms (Cancer)
01/2016

Drug/Important Bio-Agent (IBA)

1B7-H1 AntigenIBA
01/2016
1Immune Checkpoint InhibitorsIBA
01/2016
1NivolumabIBA
01/2016

Therapy/Procedure

1Therapeutics
01/2019
1Drug Therapy (Chemotherapy)
11/2013